MID-VOLUME · HOSP-HEAVY
ganciclovir Side Effects
ganciclovir (also sold as Cytovene) sits MID-VOLUME #321 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 40.2% mention hospitalization (3,970 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 9,877
- FAERS reports
FDA Adverse Event Reporting System extract for ganciclovir. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
ganciclovir: 40.2% mention hospitalization (3,970 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #321 of 524 by FAERS report count.
Mid-book FAERS page for ganciclovir (Cytovene) (9,877 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2001–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
CYTOMEGALOVIRUS INFECTION leads 1,170 of 9,877 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (2,676 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (3,034 reports, 30.7%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| CYTOMEGALOVIRUS INFECTION | 362 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 333 |
| SEPSIS | 276 |
| RESPIRATORY FAILURE | 254 |
| PANCYTOPENIA | 251 |
| PNEUMONIA | 230 |
| PYREXIA | 229 |
| SEPTIC SHOCK | 202 |
| POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER | 166 |
| DEATH | 156 |
| EPSTEIN-BARR VIRUS INFECTION | 154 |
| GRAFT VERSUS HOST DISEASE | 149 |
| RENAL FAILURE | 145 |
| CYTOMEGALOVIRUS INFECTION REACTIVATION | 140 |
| ACUTE KIDNEY INJURY | 139 |
| NEUTROPENIA | 139 |
| THROMBOCYTOPENIA | 137 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (3,970, 40.2% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| CYTOMEGALOVIRUS INFECTION | 555 |
| PYREXIA | 384 |
| DIARRHOEA | 275 |
| PANCYTOPENIA | 244 |
| PNEUMONIA | 229 |
| RESPIRATORY FAILURE | 223 |
| NEUTROPENIA | 201 |
| SEPSIS | 200 |
| ACUTE KIDNEY INJURY | 196 |
| THROMBOCYTOPENIA | 193 |
| CYTOMEGALOVIRUS INFECTION REACTIVATION | 189 |
| LEUKOPENIA | 167 |
| CONDITION AGGRAVATED | 166 |
| RENAL FAILURE | 164 |
| DRUG RESISTANCE | 160 |
| ANAEMIA | 159 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 152 |
| RENAL IMPAIRMENT | 151 |
How to read ganciclovir FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 9,877 voluntary reports linked to ganciclovir (Cytovene), 2001-2025. Death is listed on 3,034 (30.7%). Hospitalization appears on 3,970 (40.2%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 40.2% mention hospitalization (3,970 reports).
Read with ganciclovir
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 9,899 FAERS cases (Δ 22 heavier vs ganciclovir); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 9,944 FAERS cases (Δ 67 heavier vs ganciclovir); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 9,782 FAERS cases (Δ 95 lighter vs ganciclovir); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 9,780 FAERS cases (Δ 97 lighter vs ganciclovir); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 31.4 pp vs ganciclovir's DEATH-HEAVY): CASELOAD · HOSP-MID.
ganciclovir stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.